Real-Time Continuous Glucose Monitoring in Critically Ill Patients

OBJECTIVE To evaluate the impact of real-time continuous glucose monitoring (CGM) on glycemic control and risk of hypoglycemia in critically ill patients. RESEARCH DESIGN AND METHODS A total 124 patients receiving mechanical ventilation were randomly assigned to the real-time CGM group (n = 63; glucose values given every 5 min) or to the control group (n = 61; selective arterial glucose measurements according to an algorithm; simultaneously blinded CGM) for 72 h. Insulin infusion rates were guided according to the same algorithm in both groups. The primary end point was percentage of time at a glucose level <110 mg/dl. Secondary end points were mean glucose levels and rate of severe hypoglycemia (<40 mg/dl). RESULTS Percentage of time at a glucose level <110 mg/dl (59.0 ± 20 vs. 55.0 ± 18% in the control group, P = 0.245) and the mean glucose level (106 ± 18 vs. 111 ± 10 mg/dl in the control group, P = 0.076) could not be improved using real-time CGM. The rate of severe hypoglycemia was lower in the real-time CGM group (1.6 vs. 11.5% in the control group, P = 0.031). CGM reduced the absolute risk of severe hypoglycemia by 9.9% (95% CI 1.2–18.6) with a number needed to treat of 10.1 (95% CI 5.4–83.3). CONCLUSIONS In critically ill patients, real-time CGM reduces hypoglycemic events but does not improve glycemic control compared with intensive insulin therapy guided by an algorithm.

[1]  G. Steil,et al.  Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. , 2003, Diabetes technology & therapeutics.

[2]  G. Visser,et al.  The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. , 2004, Diabetes technology & therapeutics.

[3]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[4]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[5]  Luc Van Gaal,et al.  Intensive Insulin Therapy in the Intensive Care Unit , 2006, Diabetes Care.

[6]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[7]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[8]  P. Hindmarsh,et al.  Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis , 2009, Diabetes Care.

[9]  Howard Wolpert,et al.  Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2009 .

[10]  Greet Van den Berghe,et al.  Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study , 2009, The Lancet.

[11]  P. Metnitz,et al.  Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring , 2009, Intensive Care Medicine.

[12]  C. Madl,et al.  Improvement of glucose control in the intensive care unit: an interdisciplinary collaboration study. , 2008, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[13]  H. Murphy,et al.  Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial , 2008, BMJ : British Medical Journal.

[14]  Darrell M. Wilson,et al.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2010 .

[15]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[16]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[17]  R. Radermecker.  Intensive Insulin Therapy in the Intensive Care Unit: Assessment by Continuous Glucose Monitoring , 2006, Diabetes Care.

[18]  H. Murphy,et al.  Effectiveness of Continuous Glucose Monitoring in Pregnant Women With Diabetes : Randomized Clinical Trial , 2009 .

[19]  E. Renard,et al.  Continuous glucose monitoring as a tool to identify hyperglycaemia in non‐diabetic patients with acute coronary syndromes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[20]  Jaap E Tulleken,et al.  Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients , 2006, Critical care.

[21]  Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. , 2003, Diabetes & metabolism.

[22]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[23]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[24]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[25]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[26]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[27]  Sonia Caprio,et al.  Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? , 2002, Diabetes care.